GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease-Reference-Cited by-同舟云学术

GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease

Published:2016-06 Issue:1 Volume:376 Page:104-109
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Liu Jingjing,Prager–van der Smissen Wendy J.C.,Look Maxime P.,Sieuwerts Anieta M.,Smid Marcel,Meijer–van Gelder Marion E.,Foekens John A.,Hollestelle Antoinette^ORCID,Martens John W.M.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference43 articles.

1. Origins of breast cancer subtypes and therapeutic implications;Sims;Nat. Clin. Pract. Oncol,2007

2. Long term prognostic value of Nottingham histological grade and its components in early (pT1N0M0) breast carcinoma;Frkovic-Grazio;J. Clin. Pathol,2002

3. Endocrine resistance in breast cancer – an overview and update;Clarke;Mol. Cell. Endocrinol,2015

4. Pax 2/8-regulated Gata 3 expression is necessary for morphogenesis and guidance of the nephric duct in the developing kidney;Grote;Development,2006

5. GATA-3: an unexpected regulator of cell lineage determination in skin;Kaufman;Genes Dev,2003

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GATA3 and markers of epithelial-mesenchymal transition predict long-term benefit from tamoxifen in ER-positive breast cancer;npj Breast Cancer;2024-09-06

2. Primary cutaneous adnexal adenocarcinoma not otherwise specified versus metastatic breast carcinoma: A case report and review of the literature;JAAD Case Reports;2024-09

3. ZNF503 combined with GATA3 is a prognostic factor in triple-negative breast cancer;Biomarkers;2023-04-17

4. GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 Tumors;Pathobiology;2023

5. SOX4-mediated FBW7 transcriptional upregulation confers Tamoxifen resistance in ER+ breast cancers via GATA3 downregulation;Life Sciences;2022-08